These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8728541)

  • 21. Effects of modulation of NMDA neurotransmission on response rate and duration in a conflict procedure in rats.
    Wiley JL; Compton AD; Holcomb JD; McCallum SE; Varvel SA; Porter JH; Balster RL
    Neuropharmacology; 1998 Dec; 37(12):1527-34. PubMed ID: 9886675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline.
    Witkin JM; Steele TD; Sharpe LG
    J Pharmacol Exp Ther; 1997 Jan; 280(1):46-52. PubMed ID: 8996180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of site-selective NMDA receptor antagonists in an elevated plus-maze model of anxiety in mice.
    Wiley JL; Cristello AF; Balster RL
    Eur J Pharmacol; 1995 Dec; 294(1):101-7. PubMed ID: 8788421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic treatment with 1-aminocyclopropanecarboxylic acid desensitizes behavioral responses to compounds acting at the N-methyl-D-aspartate receptor complex.
    Skolnick P; Miller R; Young A; Boje K; Trullas R
    Psychopharmacology (Berl); 1992; 107(4):489-96. PubMed ID: 1534910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The utility of excitatory amino acid (EAA) antagonists as analgesic agents. II. Assessment of the antinociceptive activity of combinations of competitive and non-competitive NMDA antagonists with agents acting at allosteric-glycine and polyamine receptor sites.
    Coderre TJ; Van Empel I
    Pain; 1994 Dec; 59(3):353-359. PubMed ID: 7708409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The novel competitive N-methyl-D-aspartate (NMDA) antagonist CGP 37849 preferentially induces phencyclidine-like behavioral effects in kindled rats: attenuation by manipulation of dopamine, alpha-1 and serotonin1A receptors.
    Löscher W; Hönack D
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1146-53. PubMed ID: 1675288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strychnine-insensitive glycine receptors in embryonic chick retina: characteristics and modulation of NMDA neurotoxicity.
    Boje KM; Skolnick P; Raber J; Fletcher RT; Chader G
    Neurochem Int; 1992 Jun; 20(4):473-86. PubMed ID: 1339019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NMDA receptor activation antagonizes the NMDA antagonist-induced antianxiety effect in the elevated plus-maze test in mice.
    Poleszak E; Serefko A; Szopa A; Wośko S; Dudka J; Wróbel A; Oniszczuk T; Wlaź P
    Pharmacol Rep; 2013; 65(5):1124-31. PubMed ID: 24399708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sustained exposure to 1-aminocyclopropanecarboxylic acid, a glycine partial agonist, alters N-methyl-D-aspartate receptor function and subunit composition.
    Fossom LH; Basile AS; Skolnick P
    Mol Pharmacol; 1995 Dec; 48(6):981-7. PubMed ID: 8848014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glycine site antagonists and partial agonists inhibit N-methyl-D-aspartate receptor-mediated [3H]arachidonic acid release in cerebellar granule cells.
    Viu E; Zapata A; Capdevila JL; Fossom LH; Skolnick P; Trullas R
    J Pharmacol Exp Ther; 1998 May; 285(2):527-32. PubMed ID: 9580593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential neuroprotective effects of the NMDA receptor-associated glycine site partial agonists 1-aminocyclopropanecarboxylic acid (ACPC) and D-cycloserine in lithium-pilocarpine status epilepticus.
    Peterson SL; Purvis RS; Griffith JW
    Neurotoxicology; 2004 Sep; 25(5):835-47. PubMed ID: 15288514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The NMDA receptor partial agonist, 1-aminocyclopropanecarboxylic acid (ACPC), reduces ethanol consumption in the rat.
    Stromberg MF; Volpicelli JR; O'Brien CP; Mackler SA
    Pharmacol Biochem Behav; 1999 Nov; 64(3):585-90. PubMed ID: 10548275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 1-aminocyclopropanecarboxylates exhibit antidepressant and anxiolytic actions in animal models.
    Trullas R; Folio T; Young A; Miller R; Boje K; Skolnick P
    Eur J Pharmacol; 1991 Oct; 203(3):379-85. PubMed ID: 1685448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 1-Aminocyclopropanecarboxylic acid protects against dynorphin A-induced spinal injury.
    Long JB; Skolnick P
    Eur J Pharmacol; 1994 Aug; 261(3):295-301. PubMed ID: 7813551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Locomotor activity and motor disturbances induced by the competitive NMDA receptor antagonist CGP 37849.
    Kolasiewicz W; Maj J
    Pol J Pharmacol; 1996; 48(5):467-79. PubMed ID: 9112688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CGP 37849 and CGP 39551: novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activity.
    Fagg GE; Olpe HR; Pozza MF; Baud J; Steinmann M; Schmutz M; Portet C; Baumann P; Thedinga K; Bittiger H
    Br J Pharmacol; 1990 Apr; 99(4):791-7. PubMed ID: 1972895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The AMPA receptor antagonist GYKI 52466 reverses the anti-cataleptic effects of the competitive NMDA receptor antagonist CGP 37849.
    Hauber W; Waldenmeier MT
    Eur J Pharmacol; 1994 May; 256(3):339-42. PubMed ID: 7913894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A partial agonist at strychnine-insensitive glycine sites facilitates spatial learning in aged rats.
    Popik P; Rygielska Z
    J Physiol Pharmacol; 1999 Mar; 50(1):139-51. PubMed ID: 10210162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological profile of NPC 17742 [2R,4R,5S-(2-amino-4,5-(1, 2-cyclohexyl)-7-phosphonoheptanoic acid)], a potent, selective and competitive N-methyl-D-aspartate receptor antagonist.
    Ferkany JW; Hamilton GS; Patch RJ; Huang Z; Borosky SA; Bednar DL; Jones BE; Zubrowski R; Willetts J; Karbon EW
    J Pharmacol Exp Ther; 1993 Jan; 264(1):256-64. PubMed ID: 8423528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discriminative stimulus effects of R-(+)-3-amino-1-hydroxypyrrolid-2-one, [(+)-HA-966], a partial agonist of the strychnine-insensitive modulatory site of the N-methyl-D-aspartate receptor.
    Witkin JM; Brave S; French D; Geter-Douglass B
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1267-73. PubMed ID: 8531091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.